CLINICAL_TRIALS
trial_result
· 2011-02-25
Clinical Trial Update: Open-label Study of Levetiracetam Intravenous Infusion in Children (1 Month-4 Years Old) With Epilepsy [Phase 2]
Summary
An open-label Phase 2 study evaluating intravenous levetiracetam in children aged 1 month to 4 years with epilepsy has completed and posted its results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: UCB Pharma SA | Conditions: Epilepsy | Phase 2 | Status: COMPLETED | Results posted: 2011-02-25